articleNew England Journal of MedicineAug 25, 2004Closed access

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

University of California San Diego · The University of Texas MD Anderson Cancer Center · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

The course of chronic lymphocytic leukemia (CLL) is variable. In aggressive disease, the CLL cells usually express an unmutated immunoglobulin heavy-chain variable-region gene (IgV(H)) and the 70-kD zeta-associated protein (ZAP-70), whereas in indolent disease, the CLL cells usually express mutated IgV(H) but lack expression of ZAP-70.

Methods

We evaluated the CLL B cells from 307 patients with CLL for ZAP-70 and mutations in the rearranged IgV(H) gene. We then investigated the association between the results and the time from diagnosis to initial therapy.

Citation impact

905
total citations
FWCI
43.65
Percentile
100%
References
24
Citations per year

Authors

14

Topics & keywords

Keywords
  • Chronic lymphocytic leukemia
  • Antibody
  • Medicine
  • Immunoglobulin heavy chain
  • Immunology
  • Molecular biology
  • Leukemia
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.